Study Suggests CBD and CBG Could Be Treatment for Chronic Liver Disease
Recent research highlights the cannabigerol therapeutic potential review for chronic liver disease. CBD and CBG show promise in addressing fatty liver disease. These findings may expand treatment options for millions affected.
DEA Marijuana Rescheduling: Key Regulatory Updates 2026
This update covers the DEA marijuana rescheduling and its impact on cannabis medicine. It highlights 20 significant regulatory items from March 11, 2026. These changes influence clinical practice and research opportunities.
Study Finds Recreational Cannabis Legalization Impacts Illegal Market Dynamics Through Law Enforcement Data
This study analyzes recreational cannabis illegal market dynamics following legalization. Understanding these dynamics helps clinicians assess risks from unregulated cannabis products. It highlights the importance of recommending licensed dispensary…
Florida Cannabis Legalization Measure Blocked from 2026 Ballot (Newsletter: March 11, 2026)
The florida cannabis legalization measure was blocked from the 2026 ballot, delaying patient access to regulated cannabis products. This setback may perpetuate reliance on unregulated cannabis with variable potency and contamination risks. Clinicians…
Understanding Teens and Cannabis Use: Patterns and Risks
Adolescent cannabis use patterns vary widely and carry potential risks for brain development and mental health. Understanding these patterns helps clinicians provide better guidance. Routine screening and education are key to addressing teen cannabis use.
Texas Hemp Industry Braces for Major Changes as New State Rules Take Effect
Texas hemp industry changes are set to impact legal compliance with new state rules measuring total THC including THCA conversion. These changes may reclassify previously compliant hemp products as controlled substances. Clinicians and patients in Texas…
Should Medicare Reimburse Cannabis Products Without FDA Approval? | Newswire
Medicare cannabis reimbursement policy remains uncertain due to the lack of FDA approval for many cannabis products. This affects clinicians' ability to guide patients on coverage and treatment options. Understanding this policy gap is crucial for…
WSU Study Finds Cannabis Use Can Distort Memory and Increase False Recall
The cannabis memory distortion study highlights how cannabis use impairs memory formation and increases false recall. This has important clinical relevance for patient safety and informed consent. Clinicians should counsel patients on these cognitive…
How Cannabis Intoxication Disrupts Multiple Memory Types
Cannabis intoxication memory disruption affects various memory systems beyond simple loss. THC can cause false recall and distort memory accuracy. Understanding these effects is crucial for clinical counseling and patient safety.
Kentucky Lawmakers Push Bill Regulating THC-Infused Beverages Like Alcohol | wdrb.com
Kentucky lawmakers are advancing legislation focused on THC beverage regulation to establish clear safety and dosing standards. This bill aims to reduce patient exposure to mislabeled or contaminated cannabis drinks. THC beverage regulation could enhance…
